• Amneal Pharmaceuticals LLC, of Bridgewater, N.J., said it entered a license and distribution deal with Hanmi Pharmaceutical Co. Ltd., of South Kora, for exclusive distribution rights to Hanmi's new drug application, currently under FDA review, for esomeprazole strontium delayed-release capsules. Financial terms were not disclosed.